Article
XPC Lys939Gln polymorphism contributes to colorectal cancer susceptibility: evidence from a meta-analysis.
Diagnostic pathology - 19 Jun 2014
Peng Qiliu, Lao Xianjun, Tang Weizhong, Chen Zhiping, Li Ruolin, Qin Xue, Li Shan
Abstract excerpt
BACKGROUND: Published studies investigating the association between XPC Lys939Gln polymorphism and colorectal cancer (CRC) risk reported inconclusive results. We performed a meta-analysis to derive a precise estimation of the relationship. METHODS: A comprehensive literature search was done in da...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
